Submissions from 2015
Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer, Timothy R. Rebbeck, Nandita Mitra, Fei Wan, Olga M. Sinilnikova, Sue Healey, Lesley McGuffog, Sylvie Mazoyer, Georgia Chenevix-Trench, Douglas F. Easton, Antonis C. Antoniou, and Katherine L. Nathanson
Weekly ixabepilone with or without biweekly bevacizumab in the treatment of recurrent or persistent uterine and ovarian/primary peritoneal/fallopian tube cancers: A retrospective review, Dana M. Roque, Elena S. Ratner, Dan-Arin Silasi, Masoud Azodi, Thomas J. Rutherford, Peter E. Schwartz, Wendelin K. Nelson, and Alessandro D. Santin
Neratinib shows efficacy in the treatment of HER2 amplified carcinosarcoma in vitro and in vivo, Carlton L. Schwab, Diana P. English, Jonathan Black, Stefania Bellone, Salvatore Lopez, Emiliano Cocco, Elena Bonazzoli, Beatrice Bussi, Federica Predolini, Francesca Ferrari, Elena Ratner, Dan-Arin Silasi, Masoud Azodi, Thomas Rutherford, Peter E. Schwartz, and Alessandro D. Santin
Adjuvant carboplatin, paclitaxel, and vaginal cuff brachytherapy for stage III endometrial cancer: analysis of outcomes and patterns of recurrence based on pathologic characteristics, Melissa Rasar Young, Susan A. Higgins, Elena Ratner, James B. Yu, Sheida Mani, Dan-Arin Silasi, Masoud Azodi, Thomas Rutherford, Peter E. Schwartz, and Shari Damast
Dacomitinib (PF-00299804), a second-generation irreversible pan-erbB receptor tyrosine kinase inhibitor, demonstrates remarkable activity against HER2-amplified uterine serous endometrial cancer in vitro, Liancheng Zhu, Salvatore Lopez, Stefania Bellone, Jonathan Black, Emiliano Cocco, Tiffany Zigras, Federica Predolini, Elena Bonazzoli, Beatrice Bussi, Zachary Stuhmer, Carlton L. Schwab, Diana P. English, Elena Ratner, Dan-Arin Silasi, Masoud Azodi, Peter E. Schwartz, Thomas J. Rutherford, and Alessandro D. Santin
Submissions from 2014
Phase I clinical trial of the mammalian target of rapamycin inhibitor everolimus in combination with oral topotecan for recurrent and advanced endometrial cancer, Carlos Acevedo-Gadea, Alessandro D. Santin, Susan A. Higgins, Shweta Urva, Elena Ratner, Dan-Arin Silasi, Masoud Azodi, Thomas Rutherford, Peter E. Schwartz, and Maysa M. Abu-Khalaf
Institutional review of primary non-hodgkin lymphoma of the female genital tract: a 33-year experience, Asima Kaleem Ahmad, Pei Hui, Babak Litkouhi, Masoud Azodi, Thomas Rutherford, Shirley McCarthy, Mina LuQing Xu, Peter E. Schwartz, and Elena Ratner
T-DM1, a novel antibody-drug conjugate, is highly effective against primary HER2 overexpressing uterine serous carcinoma in vitro and in vivo, Diana P. English, Stefania Bellone, Carlton L. Schwab, Ileana Bortolomai, Elena Bonazzoli, Emiliano Cocco, Natalia Buza, Pei Hui, Salvatore Lopez, Elena Ratner, Dan-Arin Silasi, Masoud Azodi, Peter E. Schwartz, Thomas J. Rutherford, and Alessandro D. Santin
Oral antihypertensive therapy for severe hypertension in pregnancy and postpartum: a systematic review, T Firoz, L A. Magee, K MacDonell, B A. Payne, R Gordon, M Vidler, and P von Dadelszen
Magnesium sulphate for the management of preeclampsia and eclampsia in low and middle income countries: a systematic review of tested dosing regimens, Rebecca Gordon, Laura A. Magee, Beth Payne, Tabassum Firoz, Diane Sawchuck, Domena Tu, Marianne Vidler, and Dane de Silva
Flutamide and biomarkers in women at high risk for ovarian cancer: preclinical and clinical evidence, Christine Gruessner, Angelika Gruessner, Katherine Glaser, Nisreen AbuShahin, Yi Zhou, Cynthia Laughren, Heather Wright, Samantha Pinkerton, Xiaofang Yi, Jha'nae Stoffer, Masoud Azodi, Wenxin Zheng, and Setsuko K. Chambers
Impact of body mass index on surgical outcomes and analysis of disease recurrence for patients with endometrial cancer undergoing robotic-assisted staging, Gulden Menderes, Masoud Azodi, Lindsay Clark, Xiao Xu, Lingeng Lu, Elena Ratner, Peter E. Schwartz, Thomas J. Rutherford, Alessandro D. Santin, and Dan-Arin Silasi
An unexpected mass of the urachus: a case report, Monica C. Pasternak, Jonathan D. Black, Natalia Buza, Masoud Azodi, and Aileen Gariepy
Class III β-tubulin overexpression within the tumor microenvironment is a prognostic biomarker for poor overall survival in ovarian cancer patients treated with neoadjuvant carboplatin/paclitaxel, Dana M. Roque, Natalia Buza, Michelle Glasgow, Stefania Bellone, Ileana Bortolomai, Sara Gasparrini, Emiliano Cocco, Elena Ratner, Dan-Arin Silasi, Masoud Azodi, Thomas J. Rutherford, Peter E. Schwartz, and Alessandro D. Santin
Afatinib demonstrates remarkable activity against HER2-amplified uterine serous endometrial cancer in vitro and in vivo, C L. Schwab, S Bellone, D P. English, D M. Roque, S Lopez, E Cocco, R Nicoletti, I Bortolomai, E Bonazzoli, E Ratner, D-A Silasi, M Azodi, P E. Schwartz, T J. Rutherford, and A D. Santin
Submissions from 2013
Mammaglobin B (SCGB2A1) is a novel tumour antigen highly differentially expressed in all major histological types of ovarian cancer: implications for ovarian cancer immunotherapy, S Bellone, R Tassi, M Betti, D English, E Cocco, S Gasparrini, I Bortolomai, J D. Black, P Todeschini, C Romani, A Ravaggi, E Bignotti, E Bandiera, L Zanotti, S Pecorelli, L Ardighieri, M Falchetti, C Donzelli, E R. Siegel, M Azodi, D-A Silasi, E Ratner, P E. Schwartz, T J. Rutherford, and A D. Santin
Phenotypic modifications in ovarian cancer stem cells following Paclitaxel treatment, Vinicius Craveiro, Yang Yang-Hartwich, Jennie C. Holmberg, Won Duk Joo, Natalia J. Sumi, John Pizzonia, Brian Griffin, Sabrina K. Gill, Dan-Arin Silasi, Masoud Azodi, Thomas Rutherford, Ayesha B. Alvero, and Gil Mor
Measuring maternal health: focus on maternal morbidity, Tabassum Firoz, Doris Chou, Peter von Dadelszen, Priya Agrawal, Rachel Vanderkruik, Ozge Tunçalp, Laura A. Magee, and Nynke van Den Broek
Neoadjuvant chemotherapy (NACT) is an effective way of managing elderly women with advanced stage ovarian cancer (FIGO Stage IIIC and IV), Michelle A. Glasgow, Herbert Yu, Thomas J. Rutherford, Masoud Azodi, Dan-Arin Silasi, Alessandro D. Santin, and Peter E. Schwartz
Pharmacotherapy for preeclampsia in low and middle income countries: an analysis of essential medicines lists, Shifana Lalani, Tabassum Firoz, Laura A. Magee, Diane Sawchuck, Beth Payne, Rebecca Gordon, Marianne Vidler, and Peter von Dadelszen
Hereditary persistence of alpha-fetoprotein: a rare cause for unexplained alpha-fetoprotein elevations in pregnancy, Kara Rood and Robert Stiller
Tubulin-β-III overexpression by uterine serous carcinomas is a marker for poor overall survival after platinum/taxane chemotherapy and sensitivity to epothilones, Dana M. Roque, Stefania Bellone, Diana P. English, Natalia Buza, Emiliano Cocco, Sara Gasparrini, Ileana Bortolomai, Elena Ratner, Dan-Arin Silasi, Masoud Azodi, Thomas J. Rutherford, Peter E. Schwartz, and Alessandro D. Santin
Robotic versus abdominal hysterectomy for very large uteri, Dan-Arin Silasi, Taryn Gallo, Michelle Silasi, Gulden Menderes, and Masoud Azodi
Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma, Siming Zhao, Murim Choi, John D. Overton, Stefania Bellone, Dana M. Roque, Emiliano Cocco, Federica Guzzo, Diana P. English, Joyce Varughese, Sara Gasparrini, Ileana Bortolomai, Natalia Buza, Pei Hui, Maysa Abu-Khalaf, Antonella Ravaggi, Eliana Bignotti, Elisabetta Bandiera, Chiara Romani, Paola Todeschini, Renata Tassi, Laura Zanotti, Luisa Carrara, Sergio Pecorelli, Dan-Arin Silasi, Elena Ratner, Masoud Azodi, Peter E. Schwartz, Thomas J. Rutherford, Amy L. Stiegler, Shrikant Mane, Titus J. Boggon, and Joseph Schlessinger
Submissions from 2012
Downregulation of membrane complement inhibitors CD55 and CD59 by siRNA sensitises uterine serous carcinoma overexpressing Her2/neu to complement and antibody-dependent cell cytotoxicity in vitro: implications for trastuzumab-based immunotherapy, S Bellone, D Roque, E Cocco, S Gasparrini, I Bortolomai, N Buza, M Abu-Khalaf, D-A Silasi, E Ratner, M Azodi, P E. Schwartz, T J. Rutherford, S Pecorelli, and A D. Santin
Comparison between 155 cases of robotic vs. 150 cases of open surgical staging for endometrial cancer, Karim S. ElSahwi, Charlene Hooper, Maria C. De Leon, Taryn N. Gallo, Elena Ratner, Dan-Arin Silasi, Alessandro D. Santin, Peter E. Schwartz, Thomas J. Rutherford, and Masoud Azodi
A survey of gynecologic oncologists regarding the end-of-life discussion: a pilot study, Karim S. El-Sahwi, Jessica Illuzzi, Joyce Varughese, Nina Carusillo, Elena S. Ratner, Dan-Arin Silasi, Masoud Azodi, Peter E. Schwartz, Thomas J. Rutherford, and Alessandro D. Santin
Acute myocardial infarction in the obstetric patient, Tabassum Firoz and Laura A. Magee
PP088. Oral antihypertensive therapy for severe hypertension in pregnancy, T Firoz, L A. Magee, S Lalani, D Sawchuck, B Payne, M Vidler, R Gordon, and P von Dadelszen
OS032. Pharmacotherapy for pre-eclampsia in low and middle income countries: An analysis of essential medicines lists (EMLS), S Lalani, T Firoz, L A. Magee, R Lowe, D Sawchuck, B Payne, R Gordon, and M Vidler
Challenges in the diagnosis and treatment of congenital syphilis, Dallas Reed and Robert Stiller
Preeclampsia in low and middle income countries-health services lessons learned from the PRE-EMPT (PRE-Eclampsia-Eclampsia Monitoring, Prevention and Treatment) project, Peter von Dadelszen, Tabassum Firoz, France Donnay, Rebecca Gordon, G Justus Hofmeyr, Shifana Lalani, Beth A. Payne, and James M. Roberts
Submissions from 2011
Eradication of chemotherapy-resistant CD44+ human ovarian cancer stem cells in mice by intraperitoneal administration of Clostridium perfringens enterotoxin, Francesca Casagrande, Emiliano Cocco, Stefania Bellone, Christine E. Richter, Marta Bellone, Paola Todeschini, Eric Siegel, Joyce Varughese, Dan Arin-Silasi, Masoud Azodi, Thomas J. Rutherford, Sergio Pecorelli, Peter E. Schwartz, and Alessandro D. Santin
Expression of tissue factor in adenocarcinoma and squamous cell carcinoma of the uterine cervix: implications for immunotherapy with hI-con1, a factor VII-IgGFc chimeric protein targeting tissue factor, Emiliano Cocco, Joyce Varughese, Natalia Buza, Stefania Bellone, Michelle Glasgow, Marta Bellone, Paola Todeschini, Luisa Carrara, Dan-Arin Silasi, Masoud Azodi, Peter E. Schwartz, Thomas J. Rutherford, Sergio Pecorelli, Charles J. Lockwood, and Alessandro D. Santin
Tissue factor expression in ovarian cancer: implications for immunotherapy with hI-con1, a factor VII-IgGF(c) chimeric protein targeting tissue factor, Emiliano Cocco, Joyce Varughese, Natalia Buza, Stefania Bellone, Ken-Yu Lin, Marta Bellone, Paola Todeschini, Dan-Arin Silasi, Masoud Azodi, Peter E. Schwartz, Thomas J. Rutherford, Luisa Carrara, Renata Tassi, Sergio Pecorelli, Charles J. Lockwood, and Alessandro D. Santin
The significance of perineural invasion in early-stage cervical cancer, Karim S. Elsahwi, Emma Barber, Jessica Illuzzi, Natalia Buza, Elena Ratner, Dan-Arin Silasi, Alessandro D. Santin, Masoud Azodi, Peter E. Schwartz, and Thomas J. Rutherford
Postpartum evaluation and long term implications, Tabassum Firoz and Tanya Melnik
Pre-eclampsia in low and middle income countries, Tabassum Firoz, Harshad Sanghvi, Mario Merialdi, and Peter von Dadelszen
Uterine and ovarian carcinosarcomas overexpressing Trop-2 are sensitive to hRS7, a humanized anti-Trop-2 antibody, Rhoda Raji, Federica Guzzo, Luisa Carrara, Joyce Varughese, Emiliano Cocco, Stefania Bellone, Marta Betti, Paola Todeschini, Sara Gasparrini, Elena Ratner, Dan-Arin Silasi, Masoud Azodi, Peter Schwartz, Thomas J. Rutherford, Natalia Buza, Sergio Pecorelli, and Alessandro D. Santin
Her2/neu extracellular domain shedding in uterine serous carcinoma: implications for immunotherapy with trastuzumab, P Todeschini, E Cocco, S Bellone, J Varughese, K Lin, L Carrara, F Guzzo, N Buza, P Hui, D-A Silasi, E Ratner, M Azodi, P E. Schwartz, T J. Rutherford, S Pecorelli, and A D. Santin
Cervical carcinomas overexpress human trophoblast cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized monoclonal anti-Trop-2 antibody, Joyce Varughese, Emiliano Cocco, Stefania Bellone, Elena Ratner, Dan-Arin Silasi, Masoud Azodi, Peter E. Schwartz, Thomas J. Rutherford, Natalia Buza, Sergio Pecorelli, and Alessandro D. Santin
Submissions from 2010
hI-con1, a factor VII-IgGFc chimeric protein targeting tissue factor for immunotherapy of uterine serous papillary carcinoma, E Cocco, Z Hu, C E. Richter, S Bellone, F Casagrande, M Bellone, P Todeschini, G Krikun, D-A Silasi, M Azodi, P E. Schwartz, T J. Rutherford, N Buza, S Pecorelli, C J. Lockwood, and A D. Santin
Cerebral venous sinus thrombosis in a woman using the etonogestrel-ethinyl estradiol vaginal contraceptive ring: a case report, Caitlin Dunne, Doug Malyuk, and Tabassum Firoz
Overexpression of EpCAM in uterine serous papillary carcinoma: implications for EpCAM-specific immunotherapy with human monoclonal antibody adecatumumab (MT201), Karim El-Sahwi, Stefania Bellone, Emiliano Cocco, Francesca Casagrande, Marta Bellone, Maysa Abu-Khalaf, Natalia Buza, Fattaneh A. Tavassoli, Pei Hui, Dominik Rüttinger, Dan-Arin Silasi, Masoud Azodi, Peter E. Schwartz, Thomas J. Rutherford, Sergio Pecorelli, and Alessandro D. Santin
In vitro activity of pertuzumab in combination with trastuzumab in uterine serous papillary adenocarcinoma, K El-Sahwi, S Bellone, E Cocco, M Cargnelutti, F Casagrande, M Bellone, M Abu-Khalaf, N Buza, F A. Tavassoli, P Hui, D-A Silasi, M Azodi, P E. Schwartz, T J. Rutherford, S Pecorelli, and A D. Santin
Primary cervical carcinoma cell lines overexpress epithelial cell adhesion molecule (EpCAM) and are highly sensitive to immunotherapy with MT201, a fully human monoclonal anti-EpCAM antibody, Christine E. Richter, Emiliano Cocco, Stefania Bellone, Marta Bellone, Francesca Casagrande, Paola Todeschini, Dominik Rüttinger, Dan-Arin Silasi, Masoud Azodi, Peter E. Schwartz, Thomas J. Rutherford, Sergio Pecorelli, and Alessandro D. Santin
High-grade, chemotherapy-resistant ovarian carcinomas overexpress epithelial cell adhesion molecule (EpCAM) and are highly sensitive to immunotherapy with MT201, a fully human monoclonal anti-EpCAM antibody, Christine E. Richter, Emiliano Cocco, Stefania Bellone, Dan-Arin Silasi, Dominik Rüttinger, Masoud Azodi, Peter E. Schwartz, Thomas J. Rutherford, Sergio Pecorelli, and Alessandro D. Santin
HER-2/NEU overexpression in vulvar Paget disease: the Yale experience, Christine E. Richter, Pei Hui, Natalia Buza, Dan-Arin Silasi, Masoud Azodi, Alessandro D. Santin, Peter E. Schwartz, and Thomas J. Rutherford
Submissions from 2009
Generation of CA125-specific cytotoxic T lymphocytes in human leukocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancer, Stefania Bellone, Simone Anfossi, Timothy J. O'Brien, Martin J. Cannon, Dan-Arin Silasi, Masoud Azodi, Peter E. Schwartz, Thomas J. Rutherford, Sergio Pecorelli, and Alessandro D. Santin
Induction of human tumor-associated differentially expressed gene-12 (TADG-12/TMPRSS3)-specific cytotoxic T lymphocytes in human lymphocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancer, Stefania Bellone, Simone Anfossi, Timothy J. O'Brien, Martin J. Cannon, Dan-Arin Silasi, Masoud Azodi, Peter E. Schwartz, Thomas J. Rutherford, Sergio Pecorelli, and Alessandro D. Santin
Human papillomavirus type 16 (HPV-16) virus-like particle L1-specific CD8+ cytotoxic T lymphocytes (CTLs) are equally effective as E7-specific CD8+ CTLs in killing autologous HPV-16-positive tumor cells in cervical cancer patients: implications for L1 dendritic cell-based therapeutic vaccines, Stefania Bellone, Karim El-Sahwi, Emiliano Cocco, Francesca Casagrande, Marilisa Cargnelutti, Michela Palmieri, Eliana Bignotti, Chiara Romani, Dan-Arin Silasi, Masoud Azodi, Peter E. Schwartz, Thomas J. Rutherford, Sergio Pecorelli, and Alessandro D. Santin
Overexpression of epithelial cell adhesion molecule in primary, metastatic, and recurrent/chemotherapy-resistant epithelial ovarian cancer: implications for epithelial cell adhesion molecule-specific immunotherapy, Stefania Bellone, Eric R. Siegel, Emiliano Cocco, Marilisa Cargnelutti, Dan-Arin Silasi, Masoud Azodi, Peter E. Schwartz, Thomas J. Rutherford, Sergio Pecorelli, and Alessandro D. Santin
Serum amyloid A (SAA): a novel biomarker for uterine serous papillary cancer, E Cocco, S Bellone, K El-Sahwi, M Cargnelutti, F Casagrande, N Buza, F A. Tavassoli, E R. Siegel, I Visintin, E Ratner, D-A Silasi, M Azodi, P E. Schwartz, T J. Rutherford, S Pecorelli, and A D. Santin
Primary atony of the lower uterine segment as a distinct cause of early postpartum haemorrhage: a case series and management recommendations, B Panda, S Laifer, R Stiller, and G Kleinman
Antibiotic resistance and penicillin tolerance in ano-vaginal group B streptococci, Britta Panda, Igor Iruretagoyena, Robert Stiller, and Alexander Panda
Prenatal diagnosis of ectopic intrathoracic kidney in a fetus with a left diaphragmatic hernia, Britta Panda, Victor Rosenberg, Daniel Cornfeld, and Robert Stiller
Prenatal diagnosis of an umbilical vein aneurysm: a case report, Britta Panda, Robert Stiller, Igor Iruretagoyena, and Angelique Levi
Brain metastases in epithelial ovarian and primary peritoneal carcinoma, Elena S. Ratner, Eugene Toy, David M. O'Malley, Jessica McAlpine, Thomas J. Rutherford, Masoud Azodi, Susan A. Higgins, and Peter E. Schwartz
Ovarian preservation and staging in reproductive-age endometrial cancer patients, Christine E. Richter, Biyun Qian, Maritza Martel, Herbert Yu, Masoud Azodi, Thomas J. Rutherford, and Peter E. Schwartz
Submissions from 2008
Carcinosarcoma of the ovary, D-A Silasi, J L. Illuzzi, M G. Kelly, T J. Rutherford, G Mor, M Azodi, and P E. Schwartz
Submissions from 2007
Neoadjuvant chemotherapy lessens surgical morbidity in advanced ovarian cancer and leads to improved survival in stage IV disease, June Y. Hou, Michael G. Kelly, Herbert Yu, Jessica N. McAlpine, Masoud Azodi, Thomas J. Rutherford, and Peter E. Schwartz
Submissions from 2006
Lutheran b blood group alloimmunization: case series and literature review, Shabnam Kashani and Robert J. Stiller
Atypical presentations of carboplatin hypersensitivity reactions: characterization and management in patients with gynecologic malignancies, Jessica N. McAlpine, Michael G. Kelly, David M. O'malley, Masoud Azodi, Karen Coombe, Peter E. Schwartz, and Thomas J. Rutherford
MyD88 predicts chemoresistance to paclitaxel in epithelial ovarian cancer, Dan-Arin Silasi, Ayesha B. Alvero, Jessica Illuzzi, Michael Kelly, Rui Chen, Han-Hsuan Fu, Peter Schwartz, Thomas Rutherford, Masoud Azodi, and Gil Mor
Submissions from 2005
Glyceraldehyde-3-phosphate dehydrogenase binds to the AU-Rich 3' untranslated region of colony-stimulating factor-1 (CSF-1) messenger RNA in human ovarian cancer cells: possible role in CSF-1 posttranscriptional regulation and tumor phenotype, Nathalie Bonafé, Maureen Gilmore-Hebert, Nancy L. Folk, Masoud Azodi, Yi Zhou, and Setsuko K. Chambers
Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy, Michael G. Kelly, David M. O'malley, Pei Hui, Jessica McAlpine, Herbert Yu, Thomas J. Rutherford, Masoud Azodi, and Peter E. Schwartz
A comparison of urinary and sexual outcomes in women experiencing vaginal and Caesarean births, Michael C. Klein, Janusz Kaczorowski, Tabassum Firoz, Maria Hubinette, Sally Jorgensen, and Robert Gauthier
Extrarenal Wilms' tumor of the uterine corpus, J McAlpine, M Azodi, D O'Malley, M Kelly, G Golenewsky, M Martel, T Rutherford, and F Tavassoli
Weekly topotecan in heavily pretreated patients with recurrent epithelial ovarian carcinoma, David M. O'Malley, Masoud Azodi, Anita Makkenchery, Jacob Tangir, Jessica McAlpine, Michael Kelly, Peter Schwartz, and Thomas Rutherford
Submissions from 2004
Patients with uterine papillary serous cancers may benefit from adjuvant platinum-based chemoradiation, M G. Kelly, D O'Malley, P Hui, J McAlpine, J Dziura, T J. Rutherford, M Azodi, S K. Chambers, and P E. Schwartz
Submissions from 2003
Prenatal diagnosis of portal vein thrombosis by ultrasound, R J. Stiller, D Neale, D Schwartz, S Laifer, and G Kleinman
Group B streptococcal antibiotic resistance patterns in pregnant women, Robert J. Stiller, Linda Padilla, Ronika Choudhary, Thomas Tinghitella, and Steven Laifer
Submissions from 2001
Ursodeoxycholic acid for the treatment of intrahepatic cholestasis of pregnancy, S A. Laifer, R J. Stiller, D S. Siddiqui, G Dunston-Boone, and J C. Whetham
Submissions from 2000
Successful pregnancy after suspected anaphylactoid syndrome of pregnancy (amniotic fluid embolus). A case report, R J. Stiller, D Siddiqui, S A. Laifer, R L. Tiakowski, and J C. Whetham
Indicated preterm birth: a possible contribution to group B streptococcal sepsis prophylaxis protocol failures. A case report, R J. Stiller, S Vander Vennet, S A. Laifer, and J C. Whetham
Submissions from 1999
Adenocarcinoma in situ of the cervix: management and outcome, M Azodi, S K. Chambers, T J. Rutherford, E I. Kohorn, P E. Schwartz, and J T. Chambers
Pregnancy outcome after successful external cephalic version, D Siddiqui, R J. Stiller, J Collins, and S A. Laifer
The association of increased fetal nuchal translucency and spinal muscular atrophy type I, R J. Stiller, D Lieberson, R Herzlinger, D Siddiqui, S A. Laifer, and J C. Whetham
Submissions from 1996
Fetal ascites associated with ABO incompatibility: case report and review of the literature, R J. Stiller, R Herzlinger, S Siegel, and J C. Whetham
Submissions from 1995
Amniotic fluid polarization of fluorescence and lecithin/sphingomyelin ratio decision criteria assessed, L H. Bernstein, R Stiller, C Menzies, M McKenzie, and C Rundell
Submissions from 1993
Ovarian abscess as an unusual infectious complication of laser vaporization of the cervix: a case report, A Gassman, A Stanomauro, and R J. Stiller
Pregnancy in patients with cyclic neutropenia, T E. Polcz, R J. Stiller, and J C. Whetham
Submissions from 1991
Prenatal diagnosis of angular pregnancy, R J. Stiller and R H. de Regt
Antenatal diagnosis of fetal splenic cyst. A case report, R J. Stiller, R H. de Regt, and O G. Choy
Submissions from 1990
Elevated maternal serum alpha-fetoprotein concentration and fetal chromosomal abnormalities, R J. Stiller, R H. de Regt, S Suntag, A Baumgarten, J C. Hobbins, and M J. Mahoney
Vel isoimmunization in pregnancy, R J. Stiller, O Lardas, and R Haynes de Regt
Postpartum pulmonary embolus as an unusual cause of cortical blindness, R J. Stiller, S Leone-Tomaschoff, J Cuteri, and L Beck
Submissions from 1989
Early ultrasonic appearance of fetal bladder outlet obstruction, R J. Stiller
Rapid detection of vaginal colonization with group B streptococci by means of latex agglutination, R J. Stiller, E Blair, P Clark, and T Tinghitella
Transvaginal ultrasonography in patients at risk for ectopic pregnancy, R J. Stiller, R Haynes de Regt, and E Blair
Prenatal identification of twin reversed arterial perfusion syndrome in the first trimester, R J. Stiller, R Romero, S Pace, and J C. Hobbins
Submissions from 1988
Oligohydramnios associated with bilateral multicystic dysplastic kidneys: prenatal diagnosis at 15 weeks' gestation, R J. Stiller, M Pinto, C Heller, and J C. Hobbins
Agenesis of the pulmonary artery: an unusual cause of dyspnea in pregnancy, R J. Stiller, S Soberman, A Turetsky, C Lockwood, and R Haddad